NMRA-GCase

N/A

Report date: 2024/06/24 14:45:34
NME

Base Information

Drug NameNMRA-GCase
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionGlucosylceramidase modulatorsBeta-glucocerebrosidase modulators
TargetsGlucosylceramidaseBeta-glucocerebrosidase
Therapy Area/IndicationsNeurodegenerative DiseasesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAmgen IncNeumora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeumora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsNeurodegenerative DiseasesParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A